 Juan Monteverde, founder and managing partner at Monteverde Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating NTN Buzztime, Inc. NTN or the Company NYSE: NTN relating to its merger with Brooklyn ImmunoTherapeutics LLC. Under the terms of the agreement, the members of Brooklyn ImmunoTherapeutics LLC will collectively own 94.08 of the outstanding common stock of the combined company and NTN shareholders will collectively own 5.92 of the outstanding common stock of the combined company. 